Why We Invested: MiSalud
Bilingual primary care for America’s frontline workforce
At IGNIA we partner early with founders who are building technology-driven companies that solve structural problems for underserved populations. We look for businesses where better outcomes and better economics can coexist through thoughtful product design, a clear path to scale, and experienced leadership. MiSalud embodies all these things, which is why we are proud to have led MiSalud’s $5.5 MM Seed investment round.
MiSalud was founded to address one of the most persistent inequities in the U.S. healthcare system: access to primary care for working-class Americans. Although most employers offer health insurance, millions of frontline workers still face language barriers, inflexible schedules, limited transportation, and low trust in traditional providers. The result is chronic underutilization of preventive care and a disproportionate reliance on emergency rooms for issues that could be resolved through timely primary care, raising costs for employers, and worsening outcomes for employees.
MiSalud delivers a virtual-first, bilingual care platform designed around these realities. By pairing Mexico-based health coaches with U.S.-licensed physicians in a single app, MiSalud removes the linguistic and cost frictions that prevent workers, particularly Spanish-speaking and blue-collar employees, from accessing care when they need it. The service includes same-day acute care, chronic-condition management, mental-health support, and nutrition counseling, offering employers a scalable way to improve workforce health and reduce avoidable utilization.
The market opportunities are substantial. Out of ~163 MM workers in the U.S., an estimated 25 MM belong to industries such as agriculture, manufacturing, logistics, food service, and construction, sectors where employees struggle the most to navigate the healthcare system. MiSalud directly targets this underserved population with a culturally adapted, employer-aligned solution. While many telehealth platforms offer generalized care, few are purpose-built for the linguistic, cultural, and behavioral realities of these workers. MiSalud is already supporting 21 K+ covered lives, and the platform’s nearshore operating structure enables attractive economics as it scales—delivering a high-touch care experience while keeping costs structurally lower than traditional models.
A unique differentiator lies in MiSalud’s emerging data and AI capabilities. Through thousands of structured bilingual consultations, the company is building the Hispanic Health Index, a proprietary dataset designed to improve understanding of how conditions present and evolve among Hispanic populations. This resource, combined with MiSalud’s internal AI assistant that streamlines clinical workflows, positions the company to power future partnerships with insurers, public health organizations, and life-science companies seeking better representation and more culturally precise treatments.
MiSalud is led by a seasoned, mission-driven team. CEO Bismarck Lepe brings deep experience building and scaling global technology companies, having previously been one of Google’s early employees and founded Wizeline and Ooyala. COO Wendy Johansson, who cofounded Wizeline alongside Bismarck and helped scale Ooyala, has built user-centered digital products at organizations such as Amazon, Publicis Sapient, and AppNexus across Silicon Valley and Mexico. The team is further strengthened by Dr. Richard Boxer (Board Member & Interim Chief Medical Officer), a nationally recognized physician and health policy leader with +40 years of experience, and former Chief Medical Officer at Teladoc, where he helped scale clinical operations to 5 MM members.
Together, their expertise in product, technology, and go-to-market, paired with seasoned clinical leadership, has enabled MiSalud to execute with discipline and drive growing adoption.
IGNIA is proud to have led MiSalud’s $5.5 MM investment round and support its mission to expand access to high-quality, culturally competent healthcare for millions of workers and their families. With this new capital, MiSalud plans to scale its product and go-to-market capabilities, support the rollout of its new distribution partnerships, and accelerate growth while maintaining a disciplined path toward profitability. We are excited for the road ahead and look forward to accompanying Bismarck, Wendy, and the entire MiSalud team in this journey.